Initial public offering

Tufin Announces Launch of Secondary Public Offering of Ordinary Shares

Retrieved on:

Monday, December 2, 2019

(NYSE: TUFN) (Tufin), a company pioneering a policy-centric approach to security and IT operations, today announced that it has launched a secondary public offering of 3,500,000 ordinary shares, which are being offered by certain selling shareholders pursuant to a registration statement on Form F1 filed with the U.S. Securities and Exchange Commission (the SEC).

Key Points:

(NYSE: TUFN) (Tufin), a company pioneering a policy-centric approach to security and IT operations, today announced that it has launched a secondary public offering of 3,500,000 ordinary shares, which are being offered by certain selling shareholders pursuant to a registration statement on Form F1 filed with the U.S. Securities and Exchange Commission (the SEC).
In connection with the offering, certain selling shareholders intend to grant the underwriters an option to purchase up to an additional 525,000 ordinary shares.
Tufin will not receive any proceeds from the sale of ordinary shares.
J.P. Morgan Securities LLC, Barclays Capital Inc. and Jefferies LLC are acting as book-running managers in the offering and as representatives of the underwriters.

Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock

Retrieved on:

Monday, December 2, 2019

Biotechnology, Pharmaceutical, Genetics, Health, Financial economics, Finance, Corporate finance, Money, Initial public offering, Financial markets, Stock market, Arrowhead Pharmaceuticals, Shelf registration, Stock, Public offering

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced its intention to offer and sell 4,000,000 shares of its common stock in an underwritten offering pursuant to its existing automatic shelf registration statement.

Key Points:

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced its intention to offer and sell 4,000,000 shares of its common stock in an underwritten offering pursuant to its existing automatic shelf registration statement.
All of the shares in the proposed offering are to be sold by Arrowhead.
Arrowhead intends to grant the underwriters a 30-day option to purchase up to an additional 600,000 shares of its common stock.
Such forward-looking statements include statements regarding our expectations with respect to Arrowheads proposed public offering and the use of proceeds from the proposed public offering.

Minesto Publishes Prospectus Regarding Rights Issue and Invites to Investor Presentation

Retrieved on:

Monday, December 2, 2019

Corporate finance, Finance, Money, Economy, Initial public offering, Prospectus, Warrant, Rights issue, NASDAQ

Minesto was founded in 2007 and has operations in Sweden, Wales, Northern Ireland and Taiwan.

Key Points:

Minesto was founded in 2007 and has operations in Sweden, Wales, Northern Ireland and Taiwan.
The Minesto share (MINEST) is traded on the Nasdaq First North Growth Market.
This press release does not constitute an invitation to subscribe for shares, warrants, or units in Minesto.
A prospectus regarding the Rights Issue described in this press release has been approved and registered by the SFSA and is made available, inter alia, on the Company's website.

DBX DECEMBER 3, 2019, CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors of the December 3, 2019, Deadline to File a Motion for Lead Plaintiff in a Securities Class Action Against Dropbox Inc.

Retrieved on:

Monday, December 2, 2019

Legal, Professional services, Computing, Initial public offering, Software, Dropbox, Go software, South of Market, San Francisco, Digital technology

On August 27, 2019, Dropbox stock closed at $17.53 per share, representing a decline of more than 16% from the IPO price.

Key Points:

On August 27, 2019, Dropbox stock closed at $17.53 per share, representing a decline of more than 16% from the IPO price.
If you wish to serve as lead plaintiff, you must move the Court no later than December 3, 2019.
A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Aslan Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares

Retrieved on:

Monday, December 2, 2019

Financial economics, Finance, Money, Equity securities, Corporate finance, American depositary receipt, Initial public offering, Public offering

SINGAPORE, Dec. 02, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that it has commenced an underwritten public offering of its American Depositary Shares (ADSs) representing ordinary shares.

Key Points:

SINGAPORE, Dec. 02, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced that it has commenced an underwritten public offering of its American Depositary Shares (ADSs) representing ordinary shares.
All ADSs to be sold in the offering will be offered by ASLAN.
The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.
These forward-looking statements include, without limitation, references to ASLANs expectations regarding the anticipated final terms, timing and completion of the proposed offering, and the risk that the proposed public offering will not be consummated.

X FINANCIAL INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating X Financial on Behalf of Stockholders and Encourages Investors to Contact the Firm

Retrieved on:

Monday, December 2, 2019

Legal, Professional services, Financial markets, Financial economics, Finance, Equity securities, Stock market, Corporate finance, ADSS, American depositary receipt, Initial public offering, Security, Stock, New York Stock Exchange

Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against X Financial (NYSE: XYF) on behalf of X Financial stockholders.

Key Points:

Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against X Financial (NYSE: XYF) on behalf of X Financial stockholders.
Our investigation concerns whether X Financial has violated the federal securities laws and/or engaged in other unlawful business practices.
In September of 2018, X Financial completed its initial public offering (IPO), selling approximately 11.7 million American Depositary Shares (ADSs) at $9.50 per ADS.
On November 19, 2018, X Financial reported its financial results for its third quarter 2018 which ended only eleven days after the IPO.

Scott+Scott Attorneys at Law LLP Announces the Filing of a Securities Class Action Against X Financial (XYF)

Retrieved on:

Monday, December 2, 2019

Legal, Professional services, Initial public offering, ADSS

Scott+Scott Attorneys at Law LLP (Scott+Scott), an international shareholder and consumer rights litigation firm, announces the filing of a class action lawsuit against X Financial (X Financial or the Company) (NYSE: XYF), certain of its officers and directors, and the underwriters of the Companys September 2018 initial public offering (IPO), alleging violations of federal securities laws.

Key Points:

Scott+Scott Attorneys at Law LLP (Scott+Scott), an international shareholder and consumer rights litigation firm, announces the filing of a class action lawsuit against X Financial (X Financial or the Company) (NYSE: XYF), certain of its officers and directors, and the underwriters of the Companys September 2018 initial public offering (IPO), alleging violations of federal securities laws.
X Financial is a financial technology company based in Shenzhen, China, that operates a peer-to-peer platform that matches borrowers with lenders.
Immediately prior to the filing of the lawsuit, X Financials securities closed at $1.74 per ADS, representing an 80% decline from the price at which X Financials ADSs were sold in the IPO.
Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States.

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Yunji Inc.

Retrieved on:

Monday, December 2, 2019

Initial public offering

On May 3, 2019, the Company held its IPO in which it sold 11,217,447 shares for $11.00 per share.

Key Points:

On May 3, 2019, the Company held its IPO in which it sold 11,217,447 shares for $11.00 per share.
On this news, the Companys share price fell $1.21, nearly 11%, to close at $9.39 per share on August 22, 2019, thereby injuring investors.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
Glancy Prongay & Murray LLP, Los Angeles

Compass Diversified Holdings Announces Underwriters’ Full Exercise of Over-Allotment Option on Series C Cumulative Preferred Shares

Retrieved on:

Monday, December 2, 2019

U.S. Securities and Exchange Commission, Financial markets, Initial public offering, 73rd United States Congress, Prospectus, SEC filings, Securities Act, Forward-looking statement, Registration statement, Corporate finance, Financial economics, Red herring prospectus

You may obtain copies of the registration statement and the final prospectus for free by visiting EDGAR on the SEC web site at www.sec.gov.

Key Points:

You may obtain copies of the registration statement and the final prospectus for free by visiting EDGAR on the SEC web site at www.sec.gov.
The offering may be made only by means of a prospectus and related prospectus supplement meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
This press release may contain certain forward-looking statements, including statements with regard to the future performance of CODI.
Words such as "believes," "expects," "projects," intends and "future" or similar expressions, are intended to identify forward-looking statements.

Global Ship Lease Announces Full Exercise of Underwriters’ Option to Purchase Additional Senior Unsecured Notes Due 2024

Retrieved on:

Monday, December 2, 2019

Underwriting, Initial public offering, Actuarial science, Finance, Stock market, Money, Economy, Greenshoe

LONDON, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE: GSL) (the Company or Global Ship Lease) today announced that in connection with the Companys previously announced registered underwritten public offering (the Notes Offering) of its 8.00% Senior Unsecured Notes due 2024 (the Notes), the Company issued an additional $4.125 million aggregate principal amount of Notes on November 27, 2019, pursuant to the underwriters full exercise of their option to purchase additional Notes (the Underwriters Option).

Key Points:

LONDON, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE: GSL) (the Company or Global Ship Lease) today announced that in connection with the Companys previously announced registered underwritten public offering (the Notes Offering) of its 8.00% Senior Unsecured Notes due 2024 (the Notes), the Company issued an additional $4.125 million aggregate principal amount of Notes on November 27, 2019, pursuant to the underwriters full exercise of their option to purchase additional Notes (the Underwriters Option).
Aggregate net proceeds to the Company from the Notes Offering, including the full exercise of the Underwriters Option, were approximately $29.7 million, after the payment of underwriting discounts and commissions and estimated offering expenses.
The Company intends to use the net proceeds of the Notes Offering to repay a portion of the Companys 9.875% First Priority Secured Notes due 2022.
Following the closing of the Notes Offering and the Underwriters Option, the Company has $31.625 million aggregate principal amount of the Notes outstanding.